At our clinic, doctors can prescribe hair loss medication for up to two years for patients planning to return home. We can also provide a signed English medication certificate.
However, the amount you can bring into your home country depends on two sets of rules: Japanese regulations dictate what a doctor can prescribe, while your destination country’s laws govern what you can bring in.
How much medicine can you receive in Japan?
In Japan, the oral medication for male pattern hair loss is treated as a prescription drug. At our clinic, doctors will examine you, confirm the diagnosis, and create a treatment plan before prescribing it.
Japan’s Ministry of Health, Labor and Welfare has approved finasteride and dutasteride for male pattern hair loss. Japan’s public health insurance does not cover this treatment.
At our clinic, every patient has an in-person consultation with a doctor before starting treatment. If you start treatment the same day as your visit, we will draw blood to assess your health and monitor for side effects. You can also take oral medication home the same day.
For a patient planning to return home, our doctors can generally prescribe medication for up to two years; however, the specific amount and duration depend on the treatment plan you develop with your doctor.
Doctors typically require about six months to determine whether finasteride or dutasteride is effective. The Japanese package inserts for both medications recommend discontinuing use if you don’t improve after six months or more.
It is also advised to regularly assess whether you still need the medication. Discuss with your doctor how long you should continue taking it.
In a 24-week randomized trial of 917 men aged 20 to 50 with male pattern hair loss, dutasteride increased hair count and thickness more than finasteride and placebo.1 A 10-year follow-up of 118 men using finasteride found that some men with more advanced thinning first improved one year after starting.2
In a chart review of 126 Korean men who continued finasteride for at least five years, 85.7% improved, with thinning at the crown improving early and then remaining stable.3
Your destination country decides how much medicine you can bring in
Even with a valid Japanese prescription, another country may refuse the medicine if the ingredients, quantity, or documentation do not comply with its regulations.
Countries have different regulations on ingredients, personal-use quantities, and required documentation. The responsible agency may be a medicines regulator, a customs office, or both.
The U.S. Food and Drug Administration (FDA) states that, in most cases, it is illegal for individuals to import drugs into the U.S. for personal use.
U.S. citizens may generally bring in up to a three-month supply of medication, provided they declare in writing that it is for personal use and meet other specified conditions. Foreign nationals, on the other hand, may bring or ship a supply of medication for up to 90 days.
Your nationality may matter because some agencies have different conditions for citizens and foreign nationals. Tell the agency your nationality and the country you will enter, and ask about the applicable conditions before planning your supply.
Since these rules are beyond our control, we cannot guarantee that your supply will clear customs. Even with a signed medication certificate, customs may still prevent the medicine from passing.
Check with your own authorities before you travel
Begin by contacting the medicines regulator or customs authority in your home country. Ask about the specific ingredients, the quantity permitted for personal use, the accepted documentation, and whether you may carry a personal supply.
Please note that our clinic cannot ship medication overseas. If you’re considering mailing a personal supply, confirm this regulation with your local authority.
| What to confirm | Who to ask | Why it matters |
|---|---|---|
| That the active ingredient may enter the country | Medicines regulator or health authority | Rules differ by country and medicine |
| Personal-use quantity limit | Customs authority | A larger supply may be refused or held for review |
| Accepted documents | Border or customs office | The documents accepted differ by country |
| Whether mailing a personal supply is permitted | Postal or customs authority | Confirm the rule with your own authority before arranging a shipment |
During your visit to Japan, ask the clinic to provide the diagnosis and the name of each active ingredient in writing.
An EU survey of 4,208 people who received a prescription abroad found that 12% had problems with unfamiliar products, receiving the medicine, or reimbursement.4
In a small Dutch survey of 101 people treated abroad, records had not reached the foreign clinic in advance for 63.1%, and 22.2% were initially refused follow-up care after returning home.5
Questions to ask the clinic about your medicine
Before traveling, ask the clinic how much medication you will need for your treatment period and which documents it can provide for customs.
- How many months of medicine can I take home after my first visit?
- Will your signed English medication certificate list the diagnosis and each active ingredient?
- Can you provide English versions of the consent form, medication instructions, medical records, and receipt?
- Who should I contact if customs asks for more information?
You may contact us before scheduling your trip. Our clinics in Tokyo and Yokohama accept inquiries through the form on our Contact page, and we will respond via email.
Frequently asked questions
- Can I get several months of hair medicine at my first visit?
-
The doctor will make a decision. If the doctor examines you and you start treatment on that same day, our clinic will draw blood, and you may be able to take oral medicine home after your first visit, depending on the blood test results and the doctor’s assessment.
Please note that the amount prescribed may not last for several months. The exact amount will depend on your treatment plan. Before you travel, ask about the medication and your home country’s limits.
- Does a prescription from a Japanese clinic let me bring the medicine into any country?
-
No. A Japanese prescription shows that a doctor ordered the medicine in Japan, but each country applies its own import rules. Confirm the ingredient, quantity limit, and accepted documents with your country’s medicines regulator or customs office before you leave.
- Will an English medication certificate guarantee that the medicine passes customs?
-
No. Our doctors can provide a signed English medication certificate, but customs may still confiscate the medicine.
- How far before my trip should I check the rules?
-
Consult your local authorities before departing for Japan, and speak with your doctor about how many months’ worth of medication you should bring.
References
1. Gubelin Harcha, W., Barboza Martínez, J., Tsai, T. F., Katsuoka, K., Kawashima, M., Tsuboi, R., Barnes, A., Ferron-Brady, G., & Chetty, D. (2014). A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology, 70(3), 489-498.e3. https://doi.org/10.1016/j.jaad.2013.10.049
2. Rossi, A., Cantisani, C., Scarnò, M., Trucchia, A., Fortuna, M. C., & Calvieri, S. (2011). Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up. Dermatologic Therapy, 24(4), 455-61. https://doi.org/10.1111/j.1529-8019.2011.01441.x
3. Shin, J. W., Chung, E. H., Kim, M. B., Kim, T. O., Kim, W. I., & Huh, C. H. (2019). Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system. The Journal of Dermatology, 46(2), 139-143. https://doi.org/10.1111/1346-8138.14719
4. Panteli, D., Wagner, C., Verheyen, F., & Busse, R. (2015). Continuity of care in the cross-border context: insights from a survey of German patients treated abroad. European Journal of Public Health, 25(4), 557-63. https://doi.org/10.1093/eurpub/cku251
5. Verra, S. E., Kroeze, R., & Ruggeri, K. (2016). Facilitating safe and successful cross-border healthcare in the European Union. Health Policy, 120(6), 718-27. https://doi.org/10.1016/j.healthpol.2016.04.014





